Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Celyad Oncology SA
  6. News
  7. Summary
    CYAD   BE0974260896

CELYAD ONCOLOGY SA

(CYAD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CELYAD ONCOLOGY SA
05/17Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
AQ
05/06Celyad Oncology SA Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/05CELYAD ONCOLOGY SA : 1st quarter results
CO
05/05CELYAD ONCOLOGY SA : Proxy Statments
CO
04/01CELYAD ONCOLOGY SA : Ordinary general shareholder meeting
CO
03/25TRANSCRIPT : Celyad Oncology SA, 2021 Earnings Call, Mar 25, 2022
CI
03/25CELYAD ONCOLOGY : Reports Full Year 2021 Financial Results and Recent Business Highlights ..
PU
03/25CELYAD ONCOLOGY : Letter to Shareholders – March 2022
PU
03/24Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/24Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights
AQ
03/24CELYAD ONCOLOGY SA : Annual results
CO
03/24CELYAD ONCOLOGY SA : Mixed general shareholder meeting
CO
03/24CELYAD ONCOLOGY SA : SEC Filing 20 F
CO
03/17CELYAD ONCOLOGY : to Announce Full Year 2021 Financial Results and Host Conference Call
PU
03/02Celyad Says FDA Places Early-Stage Colorectal Cancer Trial on Clinical Hold
MT
More most relevant news
All news about CELYAD ONCOLOGY SA
05/17Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
AQ
05/06Celyad Oncology SA Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/05CELYAD ONCOLOGY SA : 1st quarter results
CO
05/05CELYAD ONCOLOGY SA : Proxy Statments
CO
04/01CELYAD ONCOLOGY SA : Ordinary general shareholder meeting
CO
03/25TRANSCRIPT : Celyad Oncology SA, 2021 Earnings Call, Mar 25, 2022
CI
03/25CELYAD ONCOLOGY : Reports Full Year 2021 Financial Results and Recent Business Highlights ..
PU
03/25CELYAD ONCOLOGY : Letter to Shareholders – March 2022
PU
03/24Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/24Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights
AQ
More news
News in other languages on CELYAD ONCOLOGY SA
05/06Celyad Oncology SA annonce ses résultats pour le premier trimestre clos le 31 mars 2022
05/06Uitdagend kwartaal voor Celyad
03/25Verlies Celyad loopt op
03/24Celyad Oncology SA annonce ses résultats pour l'année complète se terminant le 31 décem..
03/16Brussel flink in het groen
03/16Bel20 weer boven 4.000 punten
03/02CELYAD : la suspension de l'essai de phase 1b confirmée
03/02Celyad Oncology chute de 6 % en raison de la suspension par la FDA de l'essai clinique ..
03/02Amerikaanse FDA schort studie Celyad op
03/02Celyad Oncology annonce l'arrêt clinique de l'essai de phase 1b CYAD-101-002
More news
Analyst Recommendations on CELYAD ONCOLOGY SA
02/28HC Wainwright Downgrades Celyad Oncology Neutral From Buy, Shares Plunge 12% at Midday ..
MT
01/11Wells Fargo Adjusts Celyad Oncology's Price Target to $11 from $20, Keeps Overweight Ra..
MT
2021CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $15 From $17, Ma..
MT
2021CELYAD ONCOLOGY : JonesTrading Downgrades Celyad Oncology to Hold from Buy
MT
2020CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $18 From $22, Ke..
MT
More recommendations
Press releases
05/17Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
AQ
03/25CELYAD ONCOLOGY : Reports Full Year 2021 Financial Results and Recent Business Highlights ..
PU
03/25CELYAD ONCOLOGY : Letter to Shareholders – March 2022
PU
03/24Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights
AQ
03/17CELYAD ONCOLOGY : to Announce Full Year 2021 Financial Results and Host Conference Call
PU
More press releases
Official Publications
05/051st quarter results 
05/05Proxy Statments 
05/051st quarter results 
05/05Proxy Statments 
04/01Ordinary general shareholder meeting 
04/01Ordinary general shareholder meeting 
Upcoming event on CELYAD ONCOLOGY SA
08/05/22Interim 2022 Earnings Release
Upcoming sector events
07/26/22IQVIA HOLDINGS INC. : Interim 2022 Earnings Release (Projected)
07/27/22LONZA GROUP AG : Interim 2022 Earnings Release (Projected)
07/28/22SEAGEN INC. : Interim 2022 Earnings Release (Projected)
08/10/22MODERNA, INC. : Interim 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research